71 related articles for article (PubMed ID: 21691157)
1. Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers.
Lee JW; Berkowitz Z; Saraiya M
Obstet Gynecol; 2011 Jul; 118(1):4-13. PubMed ID: 21691157
[TBL] [Abstract][Full Text] [Related]
2. Abuses in human papillomavirus DNA testing.
Castle PE
Obstet Gynecol; 2011 Jul; 118(1):1-3. PubMed ID: 21691156
[No Abstract] [Full Text] [Related]
3. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.
Roland KB; Benard VB; Greek A; Hawkins NA; Saraiya M
Vaccine; 2014 Sep; 32(42):5432-5. PubMed ID: 25131744
[TBL] [Abstract][Full Text] [Related]
4. Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management.
Berkowitz Z; Saraiya M; Benard V; Yabroff KR
Obstet Gynecol; 2010 Dec; 116(6):1332-1340. PubMed ID: 21099599
[TBL] [Abstract][Full Text] [Related]
5. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
Berkowitz Z; Nair N; Saraiya M
Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
Hallett LD; Gerber MR
J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
9. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Malo TL; Perkins RB; Lee JH; Vadaparampil ST
Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
11. Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.
Benard VB; Greek A; Roland KB; Hawkins NA; Lin L; Saraiya M
J Womens Health (Larchmt); 2016 May; 25(5):422-7. PubMed ID: 27096534
[TBL] [Abstract][Full Text] [Related]
12. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
Perkins RB; Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Michel A; Whitmer A; Vadaparampil ST
Womens Health Issues; 2024; 34(3):257-267. PubMed ID: 38383228
[TBL] [Abstract][Full Text] [Related]
14. Primary HPV testing recommendations of US providers, 2015.
Cooper CP; Saraiya M
Prev Med; 2017 Dec; 105():372-377. PubMed ID: 29056319
[TBL] [Abstract][Full Text] [Related]
15. What about the partners of women with abnormal Pap or positive HPV tests?
Hoover K; Friedman A; Montaño D; Kasprzyk D; Greek A; Hogben M
Sex Transm Dis; 2009 Mar; 36(3):141-6. PubMed ID: 19174731
[TBL] [Abstract][Full Text] [Related]
16. Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.
Stoler MH; Austin RM; Zhao C
J Clin Microbiol; 2015 Sep; 53(9):2798-804. PubMed ID: 25948606
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.
Roland KB; Soman A; Benard VB; Saraiya M
Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492
[TBL] [Abstract][Full Text] [Related]
18. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
[TBL] [Abstract][Full Text] [Related]
19. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
20. Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests.
Price RA; Frank RG; Cleary PD; Goldie SJ
Med Care; 2011 Feb; 49(2):132-8. PubMed ID: 21150798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
